Table 5:
Comparison of TigerSaliva Ct results and commercially available saliva-based SARS-CoV-2 assay results.
| Sample | TigerSaliva | Commercially available saliva-based SARS-CoV-2 assay | ||
|---|---|---|---|---|
| N1 Ct | P1 Ct | Covid-19 Value | RNaseP Value | |
| D11 | 16.4 | 18.1 | 20.86 | 23.4 |
| E11 | 18.9 | 19.1 | 25.6 | 21.2 |
| F11 | 19.5 | 18.4 | 22.8 | 22.2 |
| G11 | 22.2 | 19.1 | 23.7 | 22.9 |
| H11 | 26.4 | 21.3 | 32.2 | 26.7 |
| A12 | 14.8 | 16.5 | 29.15 | 19 |
| B12 | 24 | 19.6 | 31.05 | 21.35 |
| C12 | 14.9 | 17.5 | 20.84 | 18.9 |
Both assays were performed on the same saliva samples (n =8).